OpenVSafe by OpenVAERS
Search V-safe

5FP-30029-81899

2 vaccinations 2 coded responses 4 check-ins 2 free-text entries 0 call cases
Sex
Female
Age at first dose
0-4
ZIP prefix
946 / CA
Registered
2022-08-09
Relationship
Child or adolescent in my care
Guardian
BUY-17298-58366
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2022-07-29
    Dose 1 — Moderna
  2. 2022-08-09
    Registered in v-safe
  3. 2022-08-26
    Dose 2 — Moderna
  4. 2022-09-02
    Health check-in — day 7, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  5. 2022-09-30
    Survey response — day 35, dose 2, under 3
    MedDRA: Roseola — Feeling: Good · Be unable to do your normal daily activities
    Free text: Roseola
    MedDRA releases: 2024-11 · check-in free text available
  6. 2022-10-09
    Health check-in — day 42, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  7. 2022-11-27
    Survey response — 3 months, dose 2, under 3
    MedDRA: Nasopharyngitis, Rhinorrhoea — Feeling: Good
    Free text: Colds runny noses
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12022-07-29Moderna No
22022-08-26Moderna No

Free text

Release 12 (Under 3) — day 35, dose 2, under 3

2022-09-30

Symptoms: Roseola

Release 12 (Under 3) — 3 months, dose 2, under 3

2022-11-27

Symptoms: Colds runny noses

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDNasopharyngitis · · ✓
SDRhinorrhoea · · ✓
SDRoseola · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release